El Sharouni SY - Search Results

1

Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.

El Sharouni SY, Kal HB, Barten-Van Rijbroek A, Struikmans H, Battermann JJ, Schramel FM. El Sharouni SY, et al. Anticancer Res. 2009 Dec;29(12):5219-24. Anticancer Res. 2009. PMID: 20044639 Free article.

2

Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).

van Vulpen M, Kal HB, Taphoorn MJ, El-Sharouni SY. van Vulpen M, et al. Among authors: el sharouni sy. Oncol Rep. 2002 Jul-Aug;9(4):683-8. Oncol Rep. 2002. PMID: 12066192 Review.

3

Gemcitabine as a radiosensitizer in undifferentiated tumors.

Kal HB, El Sharouni SY, Barten-van Rijbroek AD. Kal HB, et al. Among authors: el sharouni sy. Anticancer Res. 2006 Jan-Feb;26(1A):139-45. Anticancer Res. 2006. PMID: 16475690 Free article.

4

Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study.

Maas KW, El Sharouni SY, Phernambucq EC, Stigt JA, Groen HJ, Herder GJ, Van Den Borne BE, Senan S, Paul MA, Smit EF, Schramel FM. Maas KW, et al. Among authors: el sharouni sy. Anticancer Res. 2010 Oct;30(10):4237-43. Anticancer Res. 2010. PMID: 21036747 Clinical Trial.

5

Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.

Kastelijn EA, El Sharouni SY, Hofman FN, Van Putte BP, Monninkhof EM, Van Vulpen M, Schramel FM. Kastelijn EA, et al. Among authors: el sharouni sy. Anticancer Res. 2015 Oct;35(10):5607-14. Anticancer Res. 2015. PMID: 26408733

6

Changes in Pulmonary Function After Stereotactic Body Radiotherapy and After Surgery for Stage I and II Non-small Cell Lung Cancer, a Description of Two Cohorts.

Alberts L, El Sharouni SY, Hofman FN, Van Putte BP, Tromp E, Van Vulpen M, Kastelijn EA, Schramel FM. Alberts L, et al. Among authors: el sharouni sy. Anticancer Res. 2015 Dec;35(12):6773-9. Anticancer Res. 2015. PMID: 26637895

7

Feasibility of Concomitant Chemoradiotherapy in Daily Practice for Patients with NSCLC Stage III.

VAN DER Meer FS, Schramel FM, VAN Vulpen M, El Sharouni SY. VAN DER Meer FS, et al. Among authors: el sharouni sy. Anticancer Res. 2016 Sep;36(9):4673-6. doi: 10.21873/anticanres.11019. Anticancer Res. 2016. PMID: 27630311

8

Post-treatment Surveillance for Stage I and II Non-small Cell Lung Cancer: Impact on Clinical Outcome.

Karzijn R, Alberts L, Kelder JC, Hofman FN, El Sharouni SY, Kastelijn EA, Schramel FM. Karzijn R, et al. Among authors: el sharouni sy. Anticancer Res. 2016 Oct;36(10):5413-5418. doi: 10.21873/anticanres.11118. Anticancer Res. 2016. PMID: 27798908

9

Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.

El Sharouni SY, Kal HB, Battermann JJ. El Sharouni SY, et al. Br J Cancer. 2003 Dec 15;89(12):2184-9. doi: 10.1038/sj.bjc.6601418. Br J Cancer. 2003. PMID: 14676792 Free PMC article.

10

Tumour control probability of stage III inoperable non-small cell lung tumours after sequential chemo-radiotherapy.

El Sharouni SY, Kal HB, Battermann JJ. El Sharouni SY, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4655-61. Anticancer Res. 2005. PMID: 16334157 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters